Cronos (CRON) Operating Margin (2018 - 2026)

Cronos' (CRON) quarterly Operating Margin came in at 4.05% in Q1 2026, up 3820.0% year-on-year from 0.1% in Q1 2025, and up 75.91% quarter-over-quarter from 16.83% in Q4 2025.

Cronos (CRON) Operating Margin (2018 - 2026) Analysis & Trends

Cronos' Operating Margin history runs 9 years deep, the most recent figure standing at 4.05% for Q1 2026.

  • On a quarterly basis, Operating Margin rose 3820.0% year-over-year to 4.05% in Q1 2026; TTM through Mar 2026 was 10.15%, a 10206.0% increase from a year earlier, with the FY2025 full-year figure at 11.87%, up 5320.0% from the prior year.
  • Operating Margin advanced to 4.05% in Q1 2026 per CRON's latest filing, from 16.83% in the prior quarter.
  • Across five years, Operating Margin topped out at 375.83% in Q4 2024 and bottomed at 294.22% in Q1 2023.
  • The 5-year median for Operating Margin is 63.07% (2024), against an average of 57.26%.
  • Biggest YoY gain for Operating Margin was 180359 bps in 2022; the steepest drop was 157432 bps in 2022.
  • Year by year, Operating Margin stood at 64.11% in 2022, then slumped by 241 bps to 90.47% in 2023, then surged by 515 bps to 375.83% in 2024, then slumped by 104 bps to 16.83% in 2025, then jumped by 76 bps to 4.05% in 2026.
  • Per Business Quant, the three latest CRON Operating Margin figures stand at 4.05% (Q1 2026), 16.83% (Q4 2025), and 1.03% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn -4.05%

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.05%
Dec 31, 2025 -16.83%
Sep 30, 2025 -1.03%
Jun 30, 2025 -49.31%
Mar 31, 2025 -42.26%
Dec 31, 2024 375.83%
Sep 30, 2024 -272.95%
Jun 30, 2024 -40.23%
Mar 31, 2024 -63.07%
Dec 31, 2023 -90.47%
Sep 30, 2023 -87.77%
Jun 30, 2023 -79.93%
Mar 31, 2023 -294.22%
Dec 31, 2022 64.11%
Sep 30, 2022 -133.93%
Jun 30, 2022 -93.38%
Mar 31, 2022 -144.01%
Dec 31, 2021 1,638.43%
Sep 30, 2021 -1,348.65%
Jun 30, 2021 -1,896.97%